Detalhe da pesquisa
1.
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study.
J Am Acad Dermatol;
90(3): 521-529, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37871805
2.
Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies.
Br J Dermatol;
186(5): 803-813, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34978076
3.
Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening.
Med J Aust;
213(3): 118-123, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32632952
4.
Initial validation of the Hidradenitis Suppurativa Quality of Life tool in a clinical trial setting.
Br J Dermatol;
188(5): 672-673, 2023 04 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36715645
5.
A phase II study of laquinimod in Crohn's disease.
Gut;
64(8): 1227-35, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25281416
6.
Incidence of peptic ulcer bleeding in the US pediatric population.
J Pediatr Gastroenterol Nutr;
54(6): 733-6, 2012 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22357120
7.
A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis.
BMJ Open Gastroenterol;
8(1)2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34389633
8.
Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE).
RMD Open;
7(1)2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33526709
9.
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis.
Rheumatol Ther;
7(4): 793-810, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32844378
10.
NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options.
Drug Saf;
29(2): 119-32, 2006.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16454539
11.
Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency.
Eur J Endocrinol;
173(5): 541-51, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26286586
12.
Intestinal interleukin-13 in pediatric inflammatory bowel disease patients.
Inflamm Bowel Dis;
10(5): 593-8, 2004 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15472520
13.
Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.
Clin Ther;
34(8): 1828-38, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22832034
14.
Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
Dig Dis Sci;
52(2): 365-72, 2007 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17219072
15.
Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial.
Am J Gastroenterol;
100(12): 2650-7, 2005 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16393215
16.
Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.
Am J Gastroenterol;
100(9): 1914-22, 2005 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16128933
17.
Infliximab as a novel therapy for pediatric ulcerative colitis.
J Pediatr Gastroenterol Nutr;
34(3): 307-11, 2002 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11964959
18.
Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center.
Am J Gastroenterol;
98(1): 104-11, 2003 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12526944
19.
Intestinal cytokines in children with pervasive developmental disorders.
Am J Gastroenterol;
98(8): 1777-82, 2003 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12907332
20.
Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients.
Am J Gastroenterol;
97(10): 2603-8, 2002 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12385446